Information Provided By: 
Fly News Breaks for November 9, 2016
MD
Nov 9, 2016 | 08:04 EDT
As previously reported, Mizuho analyst Ann Hynes downgraded MEDNAX to Neutral from Buy citing Donald Trump's election victory, given his pledge to repeal and replace Obamacare. While it remains to be see if ACA can truly be clawed back, the fear that it will be will weigh on valuations for the time being, said Hynes, who cut her price target on MEDNAX shares to $64 from $69.
News For MD From the Last 2 Days
There are no results for your query MD
